#BEGIN_DRUGCARD DB03382

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C3H6NO3S

# Chemical_IUPAC_Name:
[(2R)-2-amino-2-carboxyethane]sulfinyl

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
S-Oxy Cysteine

# HET_ID:
CSX

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C3H6NO3S/c4-2(1-8-7)3(5)6/h2H,1,4H2,(H,5,6)/t2-/m0/s1

# InChI_Key:
InChIKey=KLKIIDDWGJYRSN-REOHCLBHSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3382

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
136.15

# Molecular_Weight_Mono:
136.006838753

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1XVQ

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-3

# Predicted_LogS:
0.54

# Predicted_Water_Solubility:
4.70e+02 g/l

# Primary_Accession_No:
DB03382

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936656

# PubChem_Substance_ID:
46509121

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01041

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
N[C@@H](C[S]=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:12 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE005674

# Drug_Target_1_GenBank_ID_Protein:
24050337

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
panD

# Drug_Target_1_Gene_Sequence:
>369 bp
TCAAGCAACCTGTACCGGAATCGCTTTCGCGGTACGTTTCATTTCATTGTCGCCTTCAAA
ATAGGCGACATTGGGTCGCCAGGTGCGAGCTTCTTCATCTGGCATGGTAACGAAGCTGGC
GATGATGACAATATCGCCGACGCTGGCGCAGTGGGCCGCCGCACCGTTAACAGAAATAAT
TCTCGAACCGCGTTCTGCCGCGATGGCATAAGTGGAGAAACGCTTGCCGTTGGTGACATT
CCAGATATCGATGGCTTCGTTTTCGAGAATACCGGCTGCGTCAAGAAAATCCTGGTCAAT
GGCGCAAGAACCTTCATAGTGCAGGTCCGCATGAGTCACTTTCACGCGGTGGAGTTTGCC
CTGCAGCAT

# Drug_Target_1_General_Function:
Coenzyme transport and metabolism

# Drug_Target_1_General_References:
12384590	Jin Q, Yuan Z, Xu J, Wang Y, Shen Y, Lu W, Wang J, Liu H, Yang J, Yang F, Zhang X, Zhang J, Yang G, Wu H, Qu D, Dong J, Sun L, Xue Y, Zhao A, Gao Y, Zhu J, Kan B, Ding K, Chen S, Cheng H, Yao Z, He B, Chen R, Ma D, Qiang B, Wen Y, Hou Y, Yu J: Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 2002 Oct 15;30(20):4432-41.
12704152	Wei J, Goldberg MB, Burland V, Venkatesan MM, Deng W, Fournier G, Mayhew GF, Plunkett G 3rd, Rose DJ, Darling A, Mau B, Perna NT, Payne SM, Runyen-Janecky LJ, Zhou S, Schwartz DC, Blattner FR: Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun. 2003 May;71(5):2775-86.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2750

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
13834

# Drug_Target_1_Name:
Aspartate 1-decarboxylase

# Drug_Target_1_Number_of_Residues:
126

# Drug_Target_1_PDB_ID:
1PQE

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF02261	Asp_decarbox

# Drug_Target_1_Protein_Sequence:
>Aspartate 1-decarboxylase precursor
MIRTMLQGKLHRVKVTHADLHYEGSCAIDQDFLDAAGILENEAIDIWNVTNGKRFSTYAI
AAERGSRIISVNGAAAHCASVGDIVIIASFVTMPDEEARTWRPNVAYFEGDNEMKRTAKA
IPVQVA

# Drug_Target_1_Reaction:
L-aspartate = beta-alanine + CO2

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
L-aspartate = beta-alanine + CO(2)

# Drug_Target_1_SwissProt_ID:
P0A793

# Drug_Target_1_SwissProt_Name:
PAND_SHIFL

# Drug_Target_1_Synonyms:
Aspartate 1-decarboxylase precursor
Aspartate alpha- decarboxylase
EC 4.1.1.11

# Drug_Target_1_Theoretical_pI:
6.09

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasm

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
PREP

# Drug_Target_2_GenBank_ID_Gene:
X74496

# Drug_Target_2_GenBank_ID_Protein:
558596

# Drug_Target_2_GeneCard_ID:
PREP

# Drug_Target_2_Gene_Name:
PREP

# Drug_Target_2_Gene_Sequence:
>2133 bp
ATGCTGTCCTTCCAGTACCCCGACGTGTACCGCGACGAGACCGCCGTACAGGATTATCAT
GGTCATAAAATTTGTGACCCTTACGCCTGGCTTGAAGACCCCGACAGTGAACAGACTAAG
GCCTTTGTGGAGGCCCAGAATAAGATTACTGTGCCATTTCTTGAGCAGTGTCCCATCAGA
GGTTTATACAAAGAGAGAATGACTGAACTATATGATTATCCCAAGTATAGTTGCCACTTC
AAGAAAGGAAAACGGTATTTTTATTTTTACAATACAGGTTTGCAGAACCAGCGAGTATTA
TATGTACAGGATTCCTTAGAGGGGGAGGCCAGAGTGTTCCTGGACCCCAACATACTGTCT
GACGATGGCACAGTGGCACTCCGAGGTTATGCGTTCAGCGAAGATGGTGAATATTTTGCC
TATGGTCTGAGTGCCAGTGGCTCAGACTGGGTGACAATCAAGTTCATGAAAGTTGATGGT
GCCAAAGAGCTTCCAGATGTGCTTGAAAGAGTCAAGTTCAGCTGTATGGCCTGGACCCAT
GATGGGAAGGGAATGTTCTACAACTCATACCCTCAACAGGATGGAAAAAGTGATGGCACA
GAGACATCTACCAATCTCCACCAAAAGCTCTACTACCATGTCTTGGGAACCGATCAGTCA
GAAGATATTTTGTGTGCTGAGTTTCCTGATGAACCTAAATGGATGGGTGGAGCTGAGTTA
TCTGATGATGGCCGCTATGTCTTGTTATCAATAAGGGAAGGATGTGATCCAGTAAACCGA
CTCTGGTACTGTGACCTACAGCAGGAATCCAGTGGCATCGCGGGAATCCTGAAGTGGGTA
AAACTGATTGACAACTTTGAAGGGGAATATGACTACGTGACCAATGAGGGGACGGTGTTC
ACATTCAAGACGAATCGCCAGTCTCCCAACTATCGCGTGATCAACATTGACTTCTGGGAT
CCTGAAGAGTCTAAGTGGAAAGTACTTGTTCCTGAGCATGAGAAAGATGTCTTAGAATGG
ATAGCTTGTGTCAGGTCCAACTTCTTGGTCTTATGCTACCTCCATGACGTCAAGAACATT
CTGCAGCTCCATGACCTGACTACTGGTGCTCTCCTTAAGACCTTCCCGCTCGATGTCGGC
AGCATTGTAGGGTACAGCGGTCAGAAGAAGGACACTGAAATCTTCTATCAGTTTACTTCC
TTTTTATCTCCAGGTATCATTTATCACTGTGATCTTACCAAAGAGGAGCTGGAGCCAAGA
GTTTTCCGAGAGGTGACCGTAAAAGGAATTGATGCTTCTGATTACCAGACAGTCCAGATT
TTCTACCCTAGCAAGGATGGTACGAAGATTCCAATGTTCATTGTGCATAAAAAAGGCATA
AAATTGGATGGCTCTCATCCAGCTTTCTTATATGGCTATGGCGGCTTCAACATATCCATC
ACACCCAACTACAGTGTTTCCAGGCTTATTTTTGTGAGACACATGGGTGGTATCCTGGCA
GTGGCCAACATCAGAGGAGGTGGCGAATATGGAGAGACGTGGCATAAAGGTGGTATCTTG
GCCAACAAACAAAACTGCTTTGATGACTTTCAGTGTGCTGCTGAGTATCTGATCAAGGAA
GGTTACACATCTCCCAAGAGGCTGACTATTAATGGAGGTTCAAATGGAGGCCTCTTAGTG
GCTGCTTGTGCAAATCAGAGACCTGACCTCTTTGGTTGTGTTATTGCCCAAGTTGGAGTA
ATGGACATGCTGAAGTTTCATAAATATACCATCGGCCATGCTTGGACCACTGATTATGGG
TGCTCGGACAGCAAACAACACTTTGAATGGCTTGTCAAATACTCTCCATTGCATAATGTG
AAGTTACCAGAAGCAGATGACATCCAGTACCCGTCCATGCTGCTCCTCACTGCTGACCAT
GATGACCGCGTGGTCCCGCTTCACTCCCTGAAGTTCATTGCCACCCTTCAGTACATCGTG
GGCCGCAGCAGGAAGCAAAGCAACCCCCTGCTTATCCACGTGGACACCAAGGCGGGCCAC
GGGGCGGGGAAGCCCACAGCCAAAGTGATAGAGGAAGTCTCAGACATGTTTGCGTTCATC
GCGCGGTGCCTGAATGTCGACTGGATTCCATAA

# Drug_Target_2_General_Function:
Amino acid transport and metabolism

# Drug_Target_2_General_References:
7959018	Vanhoof G, Goossens F, Hendriks L, De Meester I, Hendriks D, Vriend G, Van Broeckhoven C, Scharpe S: Cloning and sequence analysis of the gene encoding human lymphocyte prolyl endopeptidase. Gene. 1994 Nov 18;149(2):363-6.
8089089	Shirasawa Y, Osawa T, Hirashima A: Molecular cloning and characterization of prolyl endopeptidase from human T cells. J Biochem (Tokyo). 1994 Apr;115(4):724-9.

# Drug_Target_2_HGNC_ID:
HGNC:9358

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3873

# Drug_Target_2_Locus:
6q22

# Drug_Target_2_Molecular_Weight:
80764

# Drug_Target_2_Name:
Prolyl endopeptidase

# Drug_Target_2_Number_of_Residues:
710

# Drug_Target_2_PDB_ID:
1H2W

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00326	Peptidase_S9
PF02897	Peptidase_S9_N

# Drug_Target_2_Protein_Sequence:
>Prolyl endopeptidase
MLSFQYPDVYRDETAVQDYHGHKICDPYAWLEDPDSEQTKAFVEAQNKITVPFLEQCPIR
GLYKERMTELYDYPKYSCHFKKGKRYFYFYNTGLQNQRVLYVQDSLEGEARVFLDPNILS
DDGTVALRGYAFSEDGEYFAYGLSASGSDWVTIKFMKVDGAKELPDVLERVKFSCMAWTH
DGKGMFYNSYPQQDGKSDGTETSTNLHQKLYYHVLGTDQSEDILCAEFPDEPKWMGGAEL
SDDGRYVLLSIREGCDPVNRLWYCDLQQESSGIAGILKWVKLIDNFEGEYDYVTNEGTVF
TFKTNRQSPNYRVINIDFWDPEESKWKVLVPEHEKDVLEWIACVRSNFLVLCYLHDVKNI
LQLHDLTTGALLKTFPLDVGSIVGYSGQKKDTEIFYQFTSFLSPGIIYHCDLTKEELEPR
VFREVTVKGIDASDYQTVQIFYPSKDGTKIPMFIVHKKGIKLDGSHPAFLYGYGGFNISI
TPNYSVSRLIFVRHMGGILAVANIRGGGEYGETWHKGGILANKQNCFDDFQCAAEYLIKE
GYTSPKRLTINGGSNGGLLVAACANQRPDLFGCVIAQVGVMDMLKFHKYTIGHAWTTDYG
CSDSKQHFEWLVKYSPLHNVKLPEADDIQYPSMLLLTADHDDRVVPLHSLKFIATLQYIV
GRSRKQSNPLLIHVDTKAGHGAGKPTAKVIEEVSDMFAFIARCLNVDWIP

# Drug_Target_2_Reaction:
Hydrolysis of ---Pro! and to a lesser extent ---Ala! in oligopeptides

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Cleaves peptide bonds on the C-terminal side of prolyl residues within peptides that are up to approximately 30 amino acids long

# Drug_Target_2_SwissProt_ID:
P48147

# Drug_Target_2_SwissProt_Name:
PPCE_HUMAN

# Drug_Target_2_Synonyms:
EC 3.4.21.26
PE
Post-proline cleaving enzyme

# Drug_Target_2_Theoretical_pI:
5.58

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
Not Available

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
AE000657

# Drug_Target_3_GenBank_ID_Protein:
Not Available

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
ppx

# Drug_Target_3_Gene_Sequence:
>939 bp
TTAGGAATGATTTTCCTTTAATACTTCACTCACGAGAACGCCTTCTCTGAGTCCCCAGTC
GCTCACGATTAAACAATCCTTTTCAAAAATTTCTAAGGTTTTTAAGAATATGCCTATTCC
CGCGAGGATTACCTTTGCCCTCCTGTCCTCAACCTGCCTGAACCTCTTACTCCTTTCCTC
CGAAGGGATTTCTTTGAAAGTATCAAACCACTTCTTTATCTGTCCGTAAGTCAAAACTTT
TCCGTGAACTTTCTGTGGGTCGTAAGGGTAAACGTTATACTCAAGTGCCGCCAGAGTCGT
TATAGTTCCGCCCAGTCCCACAATCGTGTCAACAGGTTTCTTTACCTTACTAAGTTCCTT
CTCTAAAAATTCAAAAAATCTTTTGACTTCCTCTTCCGTTGGAGGGTCCTGCTTGAAGAA
GGTCTCGGTCAAGTTCACTATACCTATGGGTAGGGAAATTACTTCCCTCACTTTATACCC
CTTTCCGAAAACGTATTCCGTTGAACCACCCCCCTGGTCCACTACACAAACCTCTCCTTC
GGGCTTTAAAGAGTATGCAACCGCAAGGTAGGCATATCTCCCTTCCTGTTCGGGAGTAAT
CACTTCAACTACGAGTCCGACTTCTCTTTTTACCCTCTCCAGAAATTCCTCTGCGTTTTT
TGCCCTCCTTATTGCCTCCGTTGCTACGGCCTTTACCCGTTCTACCTTGAATTCATCAAT
TAACTTCTTATACTCCTTCAGCACCTGAATGGTTTCCTCTATCCTGTCCTCTTGAAGCCT
TCCCGTTTCCTTTACCTTTGTCCCGAGGGAGGTAATCCTTCCCCTCTCAAGGATTATGGA
GAGTTTTCCGTCTTTGATTTGGGCTATCGTTAGTCTCACGGAGTAGGAGCCTATGTCTAT
GGACGCCACCCTCATAATTGGTTTATTATCTAAAGACAT

# Drug_Target_3_General_Function:
Nucleotide transport and metabolism

# Drug_Target_3_General_References:
9537320	Deckert G, Warren PV, Gaasterland T, Young WG, Lenox AL, Graham DE, Overbeek R, Snead MA, Keller M, Aujay M, Huber R, Feldman RA, Short JM, Olsen GJ, Swanson RV: The complete genome of the hyperthermophilic bacterium Aquifex aeolicus. Nature. 1998 Mar 26;392(6674):353-8.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
5239

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
35497

# Drug_Target_3_Name:
Exopolyphosphatase

# Drug_Target_3_Number_of_Residues:
312

# Drug_Target_3_PDB_ID:
1T6C

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF02541	Ppx-GppA

# Drug_Target_3_Protein_Sequence:
>Exopolyphosphatase
MSLDNKPIMRVASIDIGSYSVRLTIAQIKDGKLSIILERGRITSLGTKVKETGRLQEDRI
EETIQVLKEYKKLIDEFKVERVKAVATEAIRRAKNAEEFLERVKREVGLVVEVITPEQEG
RYAYLAVAYSLKPEGEVCVVDQGGGSTEYVFGKGYKVREVISLPIGIVNLTETFFKQDPP
TEEEVKRFFEFLEKELSKVKKPVDTIVGLGGTITTLAALEYNVYPYDPQKVHGKVLTYGQ
IKKWFDTFKEIPSEERSKRFRQVEDRRAKVILAGIGIFLKTLEIFEKDCLIVSDWGLREG
VLVSEVLKENHS

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Not Available

# Drug_Target_3_SwissProt_ID:
O67040

# Drug_Target_3_SwissProt_Name:
O67040_AQUAE

# Drug_Target_3_Synonyms:
Not Available

# Drug_Target_3_Theoretical_pI:
8.14

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Not Available

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
Not Available

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
BX842581

# Drug_Target_4_GenBank_ID_Protein:
Not Available

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
Rv2991

# Drug_Target_4_Gene_Sequence:
>492 bp
ATGGGAACCAAACAGCGCGCCGACATCGTCATGTCCGAGGCTGAAATCGCCGACTTCGTC
AACTCGAGCCGTACCGGAACGCTGGCCACCATCGGACCCGACGGCCAGCCGCACTTGACG
GCGATGTGGTATGCCGTGATCGACGGCGAAATCTGGCTGGAGACCAAGGCCAAGTCGCAG
AAGGCCGTCAACCTCCGACGGGATCCGCGGGTGAGCTTCCTGCTTGAAGACGGCGACACC
TACGACACGCTGCGCGGCGTGTCGTTCGAGGGCGTTGCCGAGATCGTCGAGGAGCCCGAG
GCGCTGCACCGCGTCGGGGTCAGCGTGTGGGAACGCTACACCGGCCCCTACACCGACGAG
TGCAAACCGATGGTCGACCAGATGATGAACAAGCGGGTCGGTGTGCGCATCGTGGCCCGT
CGGACCCGCTCGTGGGATCACCGCAAGCTGGGGCTGCCACACATGTCGGTGGGTGGCTCG
ACCGCCCCGTAG

# Drug_Target_4_General_Function:
Involved in FMN binding

# Drug_Target_4_General_References:
12368430	Camus JC, Pryor MJ, Medigue C, Cole ST: Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv. Microbiology. 2002 Oct;148(Pt 10):2967-73.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
5240

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
18204

# Drug_Target_4_Name:
Hypothetical protein

# Drug_Target_4_Number_of_Residues:
163

# Drug_Target_4_PDB_ID:
1RFE

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF01243	Pyridox_oxidase

# Drug_Target_4_Protein_Sequence:
>Hypothetical protein
MGTKQRADIVMSEAEIADFVNSSRTGTLATIGPDGQPHLTAMWYAVIDGEIWLETKAKSQ
KAVNLRRDPRVSFLLEDGDTYDTLRGVSFEGVAEIVEEPEALHRVGVSVWERYTGPYTDE
CKPMVDQMMNKRVGVRIVARRTRSWDHRKLGLPHMSVGGSTAP

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Not Available

# Drug_Target_4_SwissProt_ID:
O53240

# Drug_Target_4_SwissProt_Name:
O53240_MYCTU

# Drug_Target_4_Synonyms:
Not Available

# Drug_Target_4_Theoretical_pI:
6.52

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
Not Available

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
BX842578

# Drug_Target_5_GenBank_ID_Protein:
Not Available

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
tpx

# Drug_Target_5_Gene_Sequence:
>498 bp
ATGGCACAGATAACCCTGCGAGGAAACGCGATCAATACCGTCGGTGAGCTACCTGCTGTC
GGATCCCCGGCCCCGGCCTTCACCCTGACCGGGGGCGATCTGGGGGTGATCAGCAGCGAC
CAGTTCCGGGGTAAGTCCGTGTTGCTGAACATCTTTCCATCCGTGGACACACCGGTGTGC
GCGACGAGTGTGCGAACCTTCGACGAGCGTGCGGCGGCAAGTGGCGCTACCGTGCTGTGT
GTCTCGAAGGATCTGCCGTTCGCCCAGAAGCGCTTCTGCGGCGCCGAGGGCACCGAAAAC
GTCATGCCCGCGTCGGCATTCCGGGACAGCTTCGGCGAGGATTACGGCGTGACCATCGCC
GACGGGCCGATGGCCGGGCTGCTCGCCCGCGCAATCGTGGTGATCGGCGCGGACGGCAAC
GTCGCCTACACGGAATTGGTGCCGGAAATCGCGCAAGAACCCAACTACGAAGCGGCGCTG
GCCGCGCTGGGCGCCTAG

# Drug_Target_5_General_Function:
Involved in oxidoreductase activity

# Drug_Target_5_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
5241

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
16896

# Drug_Target_5_Name:
Probable thiol peroxidase

# Drug_Target_5_Number_of_Residues:
165

# Drug_Target_5_PDB_ID:
1XVQ

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF08534	Redoxin

# Drug_Target_5_Protein_Sequence:
>Probable thiol peroxidase
MAQITLRGNAINTVGELPAVGSPAPAFTLTGGDLGVISSDQFRGKSVLLNIFPSVDTPVC
ATSVRTFDERAAASGATVLCVSKDLPFAQKRFCGAEGTENVMPASAFRDSFGEDYGVTIA
DGPMAGLLARAIVVIGADGNVAYTELVPEIAQEPNYEAALAALGA

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
Has antioxidant activity. Could remove peroxides or H(2)O(2) (By similarity)

# Drug_Target_5_SwissProt_ID:
P66952

# Drug_Target_5_SwissProt_Name:
TPX_MYCTU

# Drug_Target_5_Synonyms:
EC 1.11.1.-

# Drug_Target_5_Theoretical_pI:
4.12

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Cytoplasm

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
SOD1

# Drug_Target_6_GenBank_ID_Gene:
L44139

# Drug_Target_6_GenBank_ID_Protein:
Not Available

# Drug_Target_6_GeneCard_ID:
SOD1

# Drug_Target_6_Gene_Name:
SOD1

# Drug_Target_6_Gene_Sequence:
>465 bp
ATGGCGACGAAGGCCGTGTGCGTGCTGAAGGGCGACGGCCCAGTGCAGGGCATCATCAAT
TTCGAGCAGAAGGAAAGTAATGGACCAGTGAAGGTGTGGGGAAGCATTAAAGGACTGACT
GAAGGCCTGCATGGATTCCATGTTCATGAGTTTGGAGATAATACAGCAGGCTGTACCAGT
GCAGGTCCTCACTTTAATCCTCTATCCAGAAAACACGGTGGGCCAAAGGATGAAGAGAGG
CATGTTGGAGACTTGGGCAATGTGACTGCTGACAAAGATGGTGTGGCCGATGTGTCTATT
GAAGGTTCTGTGATCTCACTCTCAGGAGACCATTGCATCATTGGCCGCACACTGGTGGTC
CATGAAAAAGCAGATGACTTGGGCAAAGGTGGAAATGAAGAAAGTACAAAGACAGGAAAC
GCTGGAAGTCGTTTGGCTTGTGGTGTAATTGGGATCGCCCAATAA

# Drug_Target_6_General_Function:
Involved in copper, zinc superoxide dismutase activity

# Drug_Target_6_General_References:
2853161	Kajihara J, Enomoto M, Nishijima K, Yabuuchi M, Katoh K: Comparison of properties between human recombinant and placental copper-zinc SOD. J Biochem (Tokyo). 1988 Nov;104(5):851-4.
3160582	Levanon D, Lieman-Hurwitz J, Dafni N, Wigderson M, Sherman L, Bernstein Y, Laver-Rudich Z, Danciger E, Stein O, Groner Y: Architecture and anatomy of the chromosomal locus in human chromosome 21 encoding the Cu/Zn superoxide dismutase. EMBO J. 1985 Jan;4(1):77-84.
3889846	Hallewell RA, Masiarz FR, Najarian RC, Puma JP, Quiroga MR, Randolph A, Sanchez-Pescador R, Scandella CJ, Smith B, Steimer KS, et al.: Human Cu/Zn superoxide dismutase cDNA: isolation of clones synthesising high levels of active or inactive enzyme from an expression library. Nucleic Acids Res. 1985 Mar 25;13(6):2017-34.
6577438	Sherman L, Dafni N, Lieman-Hurwitz J, Groner Y: Nucleotide sequence and expression of human chromosome 21-encoded superoxide dismutase mRNA. Proc Natl Acad Sci U S A. 1983 Sep;80(18):5465-9.
6770891	Jabusch JR, Farb DL, Kerschensteiner DA, Deutsch HF: Some sulfhydryl properties and primary structure of human erythrocyte superoxide dismutase. Biochemistry. 1980 May 27;19(11):2310-6.
7002610	Barra D, Martini F, Bannister JV, Schinina ME, Rotilio G, Bannister WH, Bossa F: The complete amino acid sequence of human Cu/Zn superoxide dismutase. FEBS Lett. 1980 Oct 20;120(1):53-6.

# Drug_Target_6_HGNC_ID:
HGNC:11179

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
4152

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
15936

# Drug_Target_6_Name:
Superoxide dismutase [Cu-Zn]

# Drug_Target_6_Number_of_Residues:
154

# Drug_Target_6_PDB_ID:
1PU0

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF00080	Sod_Cu

# Drug_Target_6_Protein_Sequence:
>Superoxide dismutase [Cu-Zn]
MATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTS
AGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVV
HEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Destroys radicals which are normally produced within the cells and which are toxic to biological systems

# Drug_Target_6_SwissProt_ID:
P00441

# Drug_Target_6_SwissProt_Name:
SODC_HUMAN

# Drug_Target_6_Synonyms:
EC 1.15.1.1

# Drug_Target_6_Theoretical_pI:
6.07

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Not Available

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
Not Available

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
X62755

# Drug_Target_7_GenBank_ID_Protein:
Not Available

# Drug_Target_7_GeneCard_ID:
Not Available

# Drug_Target_7_Gene_Name:
npr

# Drug_Target_7_Gene_Sequence:
>1344 bp
ATGAAAGTTATTGTTTTAGGATCATCACATGGAGGTTATGAAGCGGTAGAGGAATTACTA
AATCTTCATCCTGATGCAGAAATTCAATGGTATGAGAAAGGTGATTTTATCTCATTCTTG
TCTTGTGGCATGCAGTTGTACCTAGAAGGAAAAGTGAAAGATGTTAATTCTGTTCGCTAT
ATGACTGGCGAAAAAATGGAGAGCCGTGGTGTAAATGTCTTTTCTAATACTGAAATTACA
GCGATTCAACCAAAAGAACATCAAGTGACAGTGAAAGATTTAGTGTCAGGTGAAGAACGT
GTTGAAAATTATGATAAATTAATCATCAGTCCCGGAGCTGTCCCATTTGAATTAGATATT
CCAGGTAAAGATTTGGATAATATTTACTTGATGCGTGGTCGTCAATGGGCCATTAAATTA
AAACAAAAAACAGTAGATCCAGAAGTCAATAATGTGGTTGTGATTGGTAGTGGTTATATT
GGGATTGAAGCTGCCGAAGCATTTGCAAAAGCCGGTAAAAAGGTTACCGTTATTGATATT
TTAGATCGTCCATTAGGGGTGTATCTAGATAAAGAATTTACAGATGTTTTAACAGAAGAG
ATGGAAGCCAATAACATTACCATTGCAACTGGTGAAACAGTTGAACGTTACGAAGGCGAC
GGTCGTGTGCAAAAAGTCGTTACAGATAAAAATGCGTACGATGCTGATTTGGTCGTTGTA
GCGGTTGGTGTCCGTCCAAACACTGCTTGGTTAAAAGGTACCTTAGAATTACATCCGAAT
GGCCTAATCAAGACGGATGAATACATGCGGACAAGTGAGCCAGATGTATTTGCAGTAGGG
GATGCTACGTTAATTAAATACAATCCTGCAGACACAGAAGTAAATATTGCCTTAGCAACG
AATGCTCGTAAACAAGGTCGCTTTGCTGTGAAAAACCTAGAGGAACCAGTTAAACCTTTC
CCTGGTGTTCAAGGATCTTCTGGCTTGGCCGTCTTTGATTATAAATTTGCTTCAACAGGG
ATTAACGAAGTCATGGCTCAAAAATTAGGAAAAGAAACAAAAGCGGTGACAGTAGTAGAA
GACTACTTGATGGACTTTAATCCAGACAAACAAAAAGCTTGGTTTAAATTAGTGTATGAT
CCTGAAACAACACAAATTTTAGGCGCTCAATTAATGTCAAAAGCAGATTTAACTGCAAAC
ATTAATGCTATTTCATTAGCGATTCAAGCCAAAATGACAATTGAAGACTTAGCCTATGCG
GATTTCTTCTTCCAACCAGCGTTTGACAAACCTTGGAATATTATTAATACAGCGGCTTTA
GAAGCGGTGAAACAAGAACGTTAA

# Drug_Target_7_General_Function:
Involved in oxidoreductase activity

# Drug_Target_7_General_References:
12663927	Paulsen IT, Banerjei L, Myers GS, Nelson KE, Seshadri R, Read TD, Fouts DE, Eisen JA, Gill SR, Heidelberg JF, Tettelin H, Dodson RJ, Umayam L, Brinkac L, Beanan M, Daugherty S, DeBoy RT, Durkin S, Kolonay J, Madupu R, Nelson W, Vamathevan J, Tran B, Upton J, Hansen T, Shetty J, Khouri H, Utterback T, Radune D, Ketchum KA, Dougherty BA, Fraser CM: Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science. 2003 Mar 28;299(5615):2071-4.
1719212	Ross RP, Claiborne A: Cloning, sequence and overexpression of NADH peroxidase from Streptococcus faecalis 10C1. Structural relationship with the flavoprotein disulfide reductases. J Mol Biol. 1991 Oct 5;221(3):857-71.
1942054	Stehle T, Ahmed SA, Claiborne A, Schulz GE: Structure of NADH peroxidase from Streptococcus faecalis 10C1 refined at 2.16 A resolution. J Mol Biol. 1991 Oct 20;221(4):1325-44.
2501302	Poole LB, Claiborne A: The non-flavin redox center of the streptococcal NADH peroxidase. I. Thiol reactivity and redox behavior in the presence of urea. J Biol Chem. 1989 Jul 25;264(21):12322-9.
8425532	Stehle T, Claiborne A, Schulz GE: NADH binding site and catalysis of NADH peroxidase. Eur J Biochem. 1993 Jan 15;211(1-2):221-6.
8756456	Yeh JI, Claiborne A, Hol WG: Structure of the native cysteine-sulfenic acid redox center of enterococcal NADH peroxidase refined at 2.8 A resolution. Biochemistry. 1996 Aug 6;35(31):9951-7.
9214307	Crane EJ 3rd, Vervoort J, Claiborne A: 13C NMR analysis of the cysteine-sulfenic acid redox center of enterococcal NADH peroxidase. Biochemistry. 1997 Jul 15;36(28):8611-8.

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
4440

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
49566

# Drug_Target_7_Name:
NADH peroxidase

# Drug_Target_7_Number_of_Residues:
447

# Drug_Target_7_PDB_ID:
2NPX

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF00070	Pyr_redox
PF02852	Pyr_redox_dim
PF07992	Pyr_redox_2

# Drug_Target_7_Protein_Sequence:
>NADH peroxidase
MKVIVLGSSHGGYEAVEELLNLHPDAEIQWYEKGDFISFLSCGMQLYLEGKVKDVNSVRY
MTGEKMESRGVNVFSNTEITAIQPKEHQVTVKDLVSGEERVENYDKLIISPGAVPFELDI
PGKDLDNIYLMRGRQWAIKLKQKTVDPEVNNVVVIGSGYIGIEAAEAFAKAGKKVTVIDI
LDRPLGVYLDKEFTDVLTEEMEANNITIATGETVERYEGDGRVQKIVTDKNAYDADLVVV
AVGVRPNTAWLKGTLELHPNGLIKTDEYMRTSEPDVFAVGDATLIKYNPADTEVNIALAT
NARKQGRFAVKNLEEPVKPFPGVQGSSGLAVFDYKFASTGINEVMAQKLGKETKAVTVVE
DYLMDFNPDKQKAWFKLVYDPETTQILGAQLMSKADLTANINAISLAIQAKMTIEDLAYA
DFFFQPAFDKPWNIINTAALEAVKQER

# Drug_Target_7_Reaction:
Not Available

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
Peroxidase whose active site is a redox-active cysteine- sulfenic acid

# Drug_Target_7_SwissProt_ID:
P37062

# Drug_Target_7_SwissProt_Name:
NAPE_ENTFA

# Drug_Target_7_Synonyms:
EC 1.11.1.1
NPXase
Npx

# Drug_Target_7_Theoretical_pI:
4.56

# Drug_Target_7_Transmembrane_Regions:
None

#END_DRUGCARD DB03382
